| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |